skip to main content
European Commission Logo
en English
Newsroom

Diabetes research: finding an alternative to insulin

The REDDSTAR project is using stem cell therapy to repair the damage induced by high glucose levels, enhancing the health and quality of life of diabetic patients, and improving available treatments.

date:  07/04/2016

ProjectRepair of Diabetic Damage by Stromal Cel...

acronymREDDSTAR

See alsoCORDIS

According to the International Diabetes Federation, in 2015 there were more than 415 million reported cases of diabetes worldwide. By 2040, this number is expected to exceed 642 million. In the EU alone, over 634 000 people died in 2010 as a result of diabetic complications. This is the equivalent of 11 % of all deaths in EU adults aged 20-79 years. Today in Europe, nearly 50 million people are using approved anti-diabetic agents to control their glucose levels. However, as insulin is the only treatment available – and its benefits are limited – controlling glucose levels and managing related complications remain a challenge.

Read more

Related Country

Related H2020 sections

Related Research areas

Health Innovation